Search

Your search keyword '"Ke, Bixia"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Ke, Bixia" Remove constraint Author: "Ke, Bixia"
122 results on '"Ke, Bixia"'

Search Results

2. Human angiotensin-converting enzyme 2–specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants

3. Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants

7. Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants

9. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract

12. Emergence of epidemic variants of SARS-CoV-2 by acquiring combinations of new highly mutable nucleotides in its genome

14. Dynamic changes in polioviruses identified by environmental surveillance in Guangzhou, 2009–2021

18. Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants

19. The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants

20. SARS-CoV-2 breakthrough infections induce somatically hypermutated broadly neutralizing antibodies against heterologous variants

22. Comparison of model‐specific histopathology in mouse models of COVID‐19

23. The adenosine analogue prodrug ATV006 is orally bioavailable and has potent preclinical efficacy against SARS-CoV-2 and its variants

24. Single-shot rAAV5-based Vaccine Provides Long-term Protective Immunity against SARS-CoV-2 and Its Variants

26. Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccineElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d2md00298a

27. The kinetics of viral load and antibodies to SARS-CoV-2

31. Antimicrobial resistance profiles of Salmonellaisolates from human diarrhea cases in China: an eight-year surveilance study

32. Serotypes, seasonal trends, and antibiotic resistance of non-typhoidal Salmonella from human patients in Guangdong Province, China, 2009–2012

36. High prevalence and diversity of pre-CTXΦ alleles in the environmentalVibrio cholerae O1 and O139 strains in the Zhujiang River estuary

37. Laboratory-Based Surveillance of Non-typhoidalSalmonellaInfections in Guangdong Province, China

39. Detection of Vibrio cholerae O1 and O139 in Environmental Water Samples by an Immunofluorescent-Aggregation Assay

40. High prevalence and diversity of pre- CTXΦ alleles in the environmental V ibrio cholerae O1 and O139 strains in the Zhujiang River estuary.

41. Epidemiology and Etiology Characteristics of Foodborne Outbreaks Caused by Vibrio parahaemolyticusDuring 2008–2010 in Guangdong Province, China

42. Laboratory-Based Surveillance of Non-typhoidal SalmonellaInfections in Guangdong Province, China

43. Prevalence of Non-Polio Enteroviruses in the Sewage of Guangzhou City, China, from 2013 to 2021.

44. Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccine.

45. Phylogenetic Analysis of Serogroup O5 Vibrio cholerae that Caused Successive Cholera Outbreaks - Guangdong Province, China, 2020-2021.

46. [Taq Man probe-based quadruple real-time PCR for detection of Salmonella paratyphi A/B/C and Salmonella typhi].

47. [Etiologic characteristics of food-borne Vibrio parahaemolyticus strains isolated in Guangdong, 2014].

48. [Etiologic characteristics of Vibrio parahaemolyticus strains causing outbreaks and sporadic cases in Guangdong, 2013].

49. [Molecular typing and surveillance on Salmonella typhimurium strain in Guangdong province, 2009-2011].

50. [Etiologic characteristics of Vibrio cholerae in Guangdong province in 2009-2013].

Catalog

Books, media, physical & digital resources